Business
Agfa Gevaert : Paul Owsianowski joins Board of Directors Agfa-Gevaert NV
Agfa Gevaert : Paul Owsianowski joins Board of Directors Agfa-Gevaert

About this update from Agfa-gevaert Nv
Non-regulated information Mortsel, Belgium - December 10, 2025 - 10:00 a.m. CET The Board of Directors of Agfa-Gevaert NV today announced that, during its meeting of December 9, 2025, it has co-opted Paul Owsianowski (AOC) as a non-executive director. He will also join the company's Audit Committee. The co-optation will take effect immediately. Paul replaces Klaus Röhrig (AOC), who indicated his wish to resign from the Board due to his increasing scope of board responsibilities. Paul Owsianowski (°1987 - German) holds a Master in Finance degree from Durham University (2011). He began his professional career in 2011 in the M&A department of Evercore Partners in London, before joining a London based private equity firm in 2014, focusing on technology related investments. In 2017, he joined Active Ownership Group (AOC). He has been a Partner of the firm since 2020. Paul has held various supervisory and non-executive board positions, including for Balabit S.à r.l., Omada A/S, GS Swiss PCB AG, and Francotyp Postalia AG (listed). Throughout his career, he focused on identifying investment opportunities, structuring of investments and process-driven value creation. Current mandates: Member of the Supervisory Board and Audit Committee at FamiCord AG (listed) Member of the Supervisory Board and Audit Committee at LPKF Laser & Electronics SE (listed) (end of message) About Agfa-Gevaert The Agfa-Gevaert Group is a leading company in imaging technology, with nearly 160 years of experience. Agfa develops, manufactures and markets analog and digital systems for the healthcare sector, for the printing industry, for the green hydrogen industry and for specific industrial applications. In 2024, the Group realized a turnover of 1,138 million euro. www.agfa.com Contact: Viviane Dictus Director Corporate Communications tel. +32 0 3 444 7124 e-mail: [email protected]